Central nervous system crystal‐storing histiocytosis: A case report and literature review

Nabeela Nathoo,Daniel P. Larson,Yong Guo,Caterina Giannini,Claudia F. Lucchinetti,Ivana N. Micallef,Karen L. Rech,Dragan Jevremovic,Daniel H. Lachance,Jithma P. Abeykoon,Ronald S. Go,W. Oliver Tobin
DOI: https://doi.org/10.1111/ene.16528
2024-10-27
European Journal of Neurology
Abstract:Background Crystal‐storing histiocytosis (CSH) is a rare form of histiocytosis with intralysosomal accumulations of immunoglobulins or paraproteins that aggregate as crystals. Central nervous system (CNS) involvement of CSH is uncommon but should be considered in cases of persistent parenchymal enhancement on neuroimaging. Methods We describe one local case of CNS CSH and 10 additional cases identified by literature review. Results Among 11 CSH patients, lesions involved either the dura (2/11) or brain parenchyma (9/11). Two cases had leptomeningeal enhancement. One case had spinal cord involvement. Two cases were associated with marginal zone lymphoma; one case was associated with an immunoglobulin A‐plasma cell dyscrasia. Eight of 11 cases had outcome data available: 7/8 cases had clinical and/or radiological improvement and 1/8 had radiological stability. Conclusions Central nervous system involvement of CSH is rare. Potential cases should be comprehensively evaluated for lymphoma or myeloma with positron emission tomography/computed tomography (CT) of the body or alternatively, CT of the chest, abdomen, pelvis and nuclear bone scan, bone marrow biopsy, serum protein electrophoresis, and cerebrospinal fluid protein electrophoresis. Treatment is targeted toward the underlying malignancy.
neurosciences,clinical neurology
What problem does this paper attempt to address?